Current Status
Not Enrolled
Get Started


Please complete the interactive infographic for this course.  When you have completed it, you will be returned here to complete the post-test and obtain your CME credit for this activity.

NOTE:  If you have not enrolled in this course, you must do so in order to receive credit.  If you do not have a CME login for this site, you will have the opportunity to register on the login page.

PLEASE LOGIN USING THE BLUE LOGIN BUTTON BEFORE CONTINUING.  If you are already logged in, the blue button will say "Logout."  If the button says "Login" then please do so and enter your credentials or enroll in this educational activity.


Click image to read bio

Eric Gertner, MD, MPH, FACP

Associate Medical Director for Quality
Lehigh Valley Physicians Group
Allentown, Pennsylvania

Read bio


Click image to read bio

Charles A. Goldthwaite, Jr.

Science Writer
Nashville, TN

Read bio



Click image to read bio

Lee Radosh, MD, FAAFP

Medical Director
Center of Excellence for Opioid Use Disorder
Reading Hospital
Tower Health System

Read bio


This Enduring Material activity, CME Infographic: New Medications for Patients with T2DM, has been reviewed and is acceptable for up to 0.50 Prescribed credit(s) by the American Academy of Family Physicians. AAFP certification begins 01/15/2020. Term of approval is for one year from this date. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Learning Objectives

  • List the potential clinical benefits for achieving glycemic control with new medications in patients with T2DM
  • Identify how new medications and combination therapy might be used in a treatment plan